1. Therapeutic potential of ALKB homologs for cardiovascular disease.
- Author
-
Xiao MZ, Liu JM, Xian CL, Chen KY, Liu ZQ, and Cheng YY
- Subjects
- AlkB Enzymes metabolism, Animals, Cardiovascular Diseases metabolism, DNA Damage drug effects, DNA Damage physiology, DNA Methylation drug effects, DNA Methylation physiology, DNA Repair drug effects, DNA Repair physiology, Humans, Oxidative Stress drug effects, Oxidative Stress physiology, Protein Structure, Secondary, AlkB Enzymes administration & dosage, AlkB Enzymes chemistry, Cardiovascular Diseases drug therapy, Drug Delivery Systems trends
- Abstract
Cardiovascular diseases (CVDs) are the leading causes of human death. Recently, ALKB homologs, including ALKBH1-8 and FTO, have been found to have a variety of biological functions, such as histone demethylation, RNA demethylation, and DNA demethylation. These functions may regulate the physiological and pathological processes of CVDs, including inflammation, oxidative stress, cell apoptosis, and mitochondrial, endothelial, and fat metabolism dysfunction. In the present review, we summarize the biological functions of ALKB homologs and the relationship between the ALKB homologs and CVDs. Importantly, we discuss the roles of ALKB homologs in the regulation of oxidative stress, inflammation, autophagy, and DNA damage in CVDs, as well as the practical applications of ALKB homologs inhibitors or agonists in treating CVDs. In conclusion, the ALKBH family might be a promising target for CVDs therapy., (Copyright © 2020 The Author(s). Published by Elsevier Masson SAS.. All rights reserved.)
- Published
- 2020
- Full Text
- View/download PDF